PL2120864T3 - Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania - Google Patents

Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania

Info

Publication number
PL2120864T3
PL2120864T3 PL07825668T PL07825668T PL2120864T3 PL 2120864 T3 PL2120864 T3 PL 2120864T3 PL 07825668 T PL07825668 T PL 07825668T PL 07825668 T PL07825668 T PL 07825668T PL 2120864 T3 PL2120864 T3 PL 2120864T3
Authority
PL
Poland
Prior art keywords
gynaecologic
rectal
administration
composition
field
Prior art date
Application number
PL07825668T
Other languages
English (en)
Inventor
Gian Paolo Strozzi
Luca Mogna
Original Assignee
Probiotical S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical S.P.A. filed Critical Probiotical S.P.A.
Publication of PL2120864T3 publication Critical patent/PL2120864T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07825668T 2006-11-28 2007-11-12 Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania PL2120864T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002286A ITMI20062286A1 (it) 2006-11-28 2006-11-28 Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
EP07825668.2A EP2120864B1 (en) 2006-11-28 2007-11-12 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof

Publications (1)

Publication Number Publication Date
PL2120864T3 true PL2120864T3 (pl) 2017-08-31

Family

ID=39468316

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07825668T PL2120864T3 (pl) 2006-11-28 2007-11-12 Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania

Country Status (11)

Country Link
US (1) US20100092440A1 (pl)
EP (1) EP2120864B1 (pl)
JP (1) JP5535641B2 (pl)
BR (1) BRPI0719549B8 (pl)
CA (1) CA2670578C (pl)
DK (1) DK2120864T3 (pl)
ES (1) ES2626841T3 (pl)
IT (1) ITMI20062286A1 (pl)
PL (1) PL2120864T3 (pl)
RU (1) RU2445073C2 (pl)
WO (1) WO2008065492A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
EP2809301A1 (en) * 2012-01-31 2014-12-10 Biosoma B.V. Method for administration of a probiotic
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20131280A1 (it) * 2013-07-30 2015-01-31 Probiotical Spa Produzione di materie prime e prodotti finiti atossici testati mediante un metodo innovativo a base di batteri probiotici per la determinazione della tossicità verso i batteri probiotici.
WO2016020861A2 (pt) * 2014-08-05 2016-02-11 Palmeira De Oliveira Ana Cristina Composição vaginal para tratamento e prevenção de infeções urogenitais, processos de obtenção e suas aplicações
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
CA3048669A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
CN110494551B (zh) * 2017-01-31 2023-06-16 庆熙大学校产学协力团 新型乳酸菌及其用途
CN113784630A (zh) * 2019-01-18 2021-12-10 Cp凯可美国公司 益生元组合物及其用途
CN112813011A (zh) * 2021-03-23 2021-05-18 北京宝源广通科技发展有限公司 一种干酪乳杆菌及其在制备水苏糖合生元酸奶中的应用
CN113558246B (zh) * 2021-07-21 2023-10-20 石河子大学 一种共生双歧杆菌复合微胶囊及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
JPH06101994B2 (ja) * 1989-08-16 1994-12-14 ユニコロイド株式会社 耐消化性腸内有用細菌及びその製法
DE4123330A1 (de) * 1991-07-15 1993-01-21 Gerhard Netz Verfahren zur peranalen keimapplikation
JPH05262657A (ja) * 1992-01-22 1993-10-12 Miyarisan Seibutsu Igaku Kenkyusho:Kk 酪酸菌含有液剤の製造法
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
JPH1121231A (ja) * 1997-07-03 1999-01-26 Okamoto Ind Inc 水溶性潤滑剤
DE69802260T2 (de) * 1998-04-30 2002-07-04 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
JP2003128588A (ja) * 2001-08-10 2003-05-08 Toray Ind Inc 多糖類含有組成物およびその用途
CN100478026C (zh) * 2001-09-28 2009-04-15 纽特休迪克斯公司 用于生物学组分的传递系统
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms

Also Published As

Publication number Publication date
EP2120864A2 (en) 2009-11-25
ES2626841T3 (es) 2017-07-26
US20100092440A1 (en) 2010-04-15
BRPI0719549B8 (pt) 2021-05-25
EP2120864B1 (en) 2017-03-22
RU2445073C2 (ru) 2012-03-20
RU2009121623A (ru) 2011-01-10
ITMI20062286A1 (it) 2008-05-29
JP2010511033A (ja) 2010-04-08
BRPI0719549B1 (pt) 2020-05-19
CA2670578C (en) 2016-01-26
BRPI0719549A2 (pt) 2014-01-21
WO2008065492A2 (en) 2008-06-05
CA2670578A1 (en) 2008-06-05
DK2120864T3 (en) 2017-05-01
WO2008065492A3 (en) 2009-03-19
JP5535641B2 (ja) 2014-07-02

Similar Documents

Publication Publication Date Title
PL2120864T3 (pl) Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania
LT2957278T (lt) Stabili kompozicija, apimanti pthrp ir jos panaudojimas
GB0413730D0 (en) A pharmaceutical composition and its use
IL179795A0 (en) A pharmaceutical composition and its use
IL197451A (en) History of Phenylamino and 4-Phenylalkylamino Quinazoline and Pharmaceuticals Containing It
IL184563A (en) Pharmaceutical foam formulations and their use
IL194751A0 (en) Drugs and uses
EP2086561A4 (en) TOPICAL FORMULATION AND ITS USES
IL195861A0 (en) Thienopyrimidine derivatives and pharmaceutical compositions containing the same
ZA200904061B (en) Fuel composition and its use
GB0713634D0 (en) Alkylacrylate copolymer dispersants and uses thereof
EP2037917A4 (en) Pharmaceutical composition comprising amlodipine and losartan
GB2443336B (en) Spiruchostatin analogues and their medicinal use
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
IL199168A0 (en) Indolizine derivatives and the use thereof as antidiabetics
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
PT1861387E (pt) Derivados de benzimidazol e composições farmacêuticas dos mesmos
GB2452696B (en) 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
GB0516069D0 (en) Pharmaceutical and use thereof
IL199178A0 (en) Aminoalcohol derivatives and their therapeutic use
IL186337A0 (en) Stannsoporfin compositions and administration
ZA200806642B (en) Novel oxidoreductases and uses thereof
GB0614365D0 (en) Pharmaceutical compositions and their use
EP1852432A4 (en) NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE